Brigit Biofarmaka Teknologi Tbk. vs J Resources Asia Pasifik Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while J Resources Asia Pasifik Tbk. trades at Rp434 (market cap 11.43T, 93.99M 24h volume). The key difference: J Resources Asia Pasifik Tbk. is far larger — about 66.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and J Resources Asia Pasifik Tbk. is more actively traded (93.99M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | PSAB | |
|---|---|---|
Market Cap | 172.82B | 11.43T |
Volume | 592.2K | 93.99M |
Lot | 5.92K | 939.89K |
Turnover | 147.05M | 40.97B |
Average Price | 248.31 | 435.89 |
Value | 147.05M | 40.97B |
Indicative Equilibrium Price | 254 | 434 |
Indicative Equilibrium Volume | 10 | 29.11K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT J Resources Asia Pasifik Tbk (the Company) was established under the name of PT Pelita Sejahtera Abadi Tbk on January 14, 2002. PT Pelita Sejahtera Abadi Tbk is an Indonesia-based service company. The Company operates food courts and provides catering services. In addition, it is engaged in the transportation, telecommunication and real estate sectors. The Company is headquartered in Semarang, Indonesia.
Read more on PSAB →